BIOMAT Database Logo BIOMAT Database Logo

Chrymutasins: novel-aglycone antitumor antibiotics from a mutant of Streptomyces chartreusis. II. Characterization and structural elucidation. 1994

H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
Pharmaceutical Research Laboratories, Sapporo Breweries Ltd., Shizuoka, Japan.

Chrymutasins A, B and C are glycosidic antibiotics produced by a mutant of the chartreusin producer-organism Streptomyces chartreusis. We report here the structure elucidation of these compounds. The sugar moieties involved were determined by comparison with the related chartreusins. The structure of the aglycone, the same in all three compounds, was elucidated by NMR, incorporation studies of labeled compounds and synthesis of derivatives. The chrymutasin aglycone differs from that of chartreusin by a single carbon and an amino group.

UI MeSH Term Description Entries
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D006027 Glycosides Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed) Glycoside
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D001578 Benzopyrans Compounds with a core of fused benzo-pyran rings. Benzopyran,Chromene,Chromenes
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016296 Mutagenesis Process of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS. Mutageneses

Related Publications

H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
A novel series of milbemycin antibiotics from Streptomyces strain E225. II. Isolation, characterization, structure elucidation and solution conformations.
September 1990, The Journal of antibiotics,
H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. II. Structural elucidation.
December 1996, The Journal of antibiotics,
H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
Helvecardins A and B, novel glycopeptide antibiotics. II. Structural elucidation.
March 1991, The Journal of antibiotics,
H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins.
May 2005, The Journal of antibiotics,
H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. III. Structural elucidation.
March 1996, The Journal of antibiotics,
H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
Characterization of three novel DyP-type peroxidases from Streptomyces chartreusis NRRL 3882.
October 2022, Journal of applied microbiology,
H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. II. Structural elucidation.
July 1993, The Journal of antibiotics,
H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
Gilvocarcins, new antitumor antibiotics. 2. Structural elucidation.
March 1981, The Journal of antibiotics,
H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
Antitumor antibiotics from streptomyces.
January 1959, Acta - Unio Internationalis Contra Cancrum,
H Uchida, and Y Nakakita, and N Enoki, and N Abe, and T Nakamura, and M Munekata
Tetrocarcins, novel antitumor antibiotics. II. Isolation, characterization and antitumor activity.
September 1980, The Journal of antibiotics,
Copied contents to your clipboard!